Back to Search
Start Over
Melanoma, version 2.2013: featured updates to the NCCN guidelines.
- Source :
-
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2013 Apr 01; Vol. 11 (4), pp. 395-407. - Publication Year :
- 2013
-
Abstract
- The NCCN Guidelines for Melanoma provide multidisciplinary recommendations on the clinical management of patients with melanoma. This NCCN Guidelines Insights report highlights notable recent updates. Foremost of these is the exciting addition of the novel agents ipilimumab and vemurafenib for treatment of advanced melanoma. The NCCN panel also included imatinib as a treatment for KIT-mutated tumors and pegylated interferon alfa-2b as an option for adjuvant therapy. Also important are revisions to the initial stratification of early-stage lesions based on the risk of sentinel lymph node metastases, and revised recommendations on the use of sentinel lymph node biopsy for low-risk groups. Finally, the NCCN panel reached clinical consensus on clarifying the role of imaging in the workup of patients with melanoma.
- Subjects :
- Algorithms
Chemotherapy, Adjuvant
Comprehensive Health Care organization & administration
Disease Progression
Education, Medical, Continuing legislation & jurisprudence
Humans
Interferons therapeutic use
Medical Oncology organization & administration
Melanoma diagnosis
Melanoma pathology
Sentinel Lymph Node Biopsy education
Sentinel Lymph Node Biopsy methods
Skin Neoplasms diagnosis
Skin Neoplasms pathology
Societies, Medical legislation & jurisprudence
Societies, Medical organization & administration
Therapies, Investigational methods
Melanoma therapy
Practice Guidelines as Topic
Skin Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1540-1413
- Volume :
- 11
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of the National Comprehensive Cancer Network : JNCCN
- Publication Type :
- Academic Journal
- Accession number :
- 23584343
- Full Text :
- https://doi.org/10.6004/jnccn.2013.0055